Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Vernerey

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
JAMA Network Open|September 14, 2023
Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant TransfusionEmilie Gaiffe, Dewi Vernerey, Laurent Bardiaux, et al.
Annals of Surgery|August 5, 2024
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 TrialJean Pinson, Julie Henriques, Ludivine Beaussire, et al.
Clinical Colorectal Cancer|June 9, 2024
Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort StudyJuliette Logeart, Thomas Samaille, Antoine Falcoz, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 26, 2025
Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single-blind phase III multicentre randomized controlled trial (FLUOCOL-01/FRENCH 21/GRECCAR 19 intergroup trial)Jean-Baptiste Pretalli, Dewi Vernerey, Philippe Evrard, et al.
Bulletin Du Cancer|July 5, 2020
Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSENoémie Gassian, Alexandre Frontczak, Guillaume Mouillet, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Exposure-response analysis of Raltitrexed assessing liver toxicityBernard Royer, Antonin Schmitt, Thierry Nguyen, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2020
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinomaPaul McLellan, Julie Henriques, Feryel Ksontini, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic CarcinomaAntoine Schernberg, Dewi Vernerey, David Goldstein, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical ActivityPauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
BMC Cancer|May 31, 2020
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)Antoine Brouquet, Jean-Baptiste Bachet, Florence Huguet, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
JAMA Network Open|September 14, 2023
Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant TransfusionEmilie Gaiffe, Dewi Vernerey, Laurent Bardiaux, et al.
Annals of Surgery|August 5, 2024
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 TrialJean Pinson, Julie Henriques, Ludivine Beaussire, et al.
Clinical Colorectal Cancer|June 9, 2024
Survival Outcomes in Patients with Monobloc-Resected Stage IIC (pT4bN0) Colon Cancer: A Retrospective Observational Cohort StudyJuliette Logeart, Thomas Samaille, Antoine Falcoz, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|May 26, 2025
Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single-blind phase III multicentre randomized controlled trial (FLUOCOL-01/FRENCH 21/GRECCAR 19 intergroup trial)Jean-Baptiste Pretalli, Dewi Vernerey, Philippe Evrard, et al.
Bulletin Du Cancer|July 5, 2020
Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSENoémie Gassian, Alexandre Frontczak, Guillaume Mouillet, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Exposure-response analysis of Raltitrexed assessing liver toxicityBernard Royer, Antonin Schmitt, Thierry Nguyen, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2020
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinomaPaul McLellan, Julie Henriques, Feryel Ksontini, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic CarcinomaAntoine Schernberg, Dewi Vernerey, David Goldstein, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical ActivityPauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
BMC Cancer|May 31, 2020
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)Antoine Brouquet, Jean-Baptiste Bachet, Florence Huguet, et al.
Pageof 16